調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Veterinary Pain Management Market by Product (Drugs (NSAIDs, Opioids), Device (Laser, Electromagnetic)), Application (Osteoarthritis, Cancer), Animal Type (Dog, Cat, Horse, Cattle), Distribution Channel (Hospital, Pharmacy) - Global Forecast to 2023

動物向け疼痛治療の世界市場予測（～2023年）

◆タイトル：Veterinary Pain Management Market by Product (Drugs (NSAIDs, Opioids), Device (Laser, Electromagnetic)), Application (Osteoarthritis, Cancer), Animal Type (Dog, Cat, Horse, Cattle), Distribution Channel (Hospital, Pharmacy) - Global Forecast to 2023
◆商品コード：MD6197
◆調査・発行会社：MarketsandMarkets
◆発行日：2018年4月20日
◆ページ数：239
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名利用）USD5,650 ⇒換算￥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥920,950見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

当調査レポートでは、動物向け疼痛治療の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（薬剤、デバイス）別分析、用途別分析、動物種類別分析、販売チャネル別分析、動物向け疼痛治療の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Global veterinary pain management market projected to grow at a CAGR of 8.0%”The global veterinary pain management market is projected to reach USD 1.66 billion by 2023 from USD 1.13 billion in 2018, at a CAGR of 8.0% during the forecast period. Factors such as growth in companion animal adoption, increasing number of veterinary practitioners and their rising income levels in developed economies, growing prevalence of animal diseases causing pain and inflammation, and rising adoption of pet insurance with growing animal health expenditure are expected to drive the growth of the market. However, increasing pet care cost may restrain market growth to a certain extent.
“By devices, laser therapy devices held the largest market share in 2017”
On the basis of devices, the market is segmented into laser and electromagnetic therapy devices. Laser therapy devices accounted for the largest share of the veterinary pain management devices market. The large share of this segment can be attributed to the effectiveness of laser therapy devices in curing a wide range of acute and chronic pain conditions in animals.
“By application, the cancer segment is expected to grow at the highest CAGR during the forecast period”
On the basis of application, the market is segmented into joint pain, postoperative pain, cancer, and other applications. The cancer segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the growing prevalence of cancer in companion animals and the requirement of pain management at every stage of cancer treatment.
“By animal type, the companion animal held the largest market share in 2017”
By animal type, the market is further segmented into companion and livestock. In 2017, the companion animals segmented accounted for the largest share of the veterinary pain management market due to increasing companion animal ownership, growing awareness about animal health among pet owners, and rising pet healthcare expenditure.
“North America is expected to grow at the largest share during the forecast period (2018-2023)”
North America dominated the veterinary pain management market in 2017, followed by Europe, Asia Pacific, Latin America, and the Middle East & Africa. In North America, the US is expected to hold the largest share of the veterinary pain management market due to the growing number of people adopting pets, increasing animal healthcare expenditure, growing veterinary practices, and increasing prevalence of chronic diseases such as cancer and osteoarthritis.
Break of primary participants was as mentioned below:
• By Company Type – Tier 1–45%, Tier 2–30% and Tier 3–25%
• By Designation – C-level–45%, Director Level–32%, Others–23%
• By Region – North America–46%, Europe–27%, Asia-Pacific–20%, Latin America–4%, Middle East & Africa- 3%

The major players in the veterinary pain management market are Zoetis(US), Merck Animal Health (US), Elanco (US), Chanelle (Ireland), Boehringer Ingelheim (Germany), Vetoquinol (France), Bayer (Germany), Norbrook (Ireland), Ceva Santé Animale (France), K-Laser (US), Assisi (US), and Dechra Pharmaceuticals (UK).
Research Coverage:
The veterinary pain management market in this report is segmented by product, application, animal type, distribution channel, and regions. It provides detailed information regarding major factors influencing the growth market (drivers, restraints, opportunities, and industry-specific challenges). The study tracks and analyzes competitive developments (such as partnerships, agreements, collaborations, mergers & acquisitions, new product developments, geographical expansions, and R&D activities) and strategically profiles the key players and comprehensively analyzes their market shares and core competencies in the veterinary pain management market.
Reasons to buy this report:
From an insight perspective, this research report has focused on various levels of analysis—market share analysis of top players, company profiles which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the veterinary pain management market; high-growth regions; and market drivers, restraints, and opportunities. The report provides the latest veterinary pain industry statistics and industry trends, allowing buyers to identify the high growth product segment and potential customers and suppliers hence driving revenue growth and profitability.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on pain management products offered by the top players in the global veterinary pain management market

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the veterinary pain management market

• Market Development: Comprehensive information about lucrative emerging markets – the report analyzes the markets for veterinary pain management market across regions

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global veterinary pain management market

• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global veterinary pain management market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 MARKET SCOPE 20
1.3.1 MARKETS COVERED 21
1.3.2 YEARS CONSIDERED FOR THE STUDY 22
1.4 CURRENCY 22
1.5 STAKEHOLDERS 23
2 RESEARCH METHODOLOGY 24
2.1 RESEARCH DATA 24
2.1.1 SECONDARY SOURCES 25
2.1.1.1 Key data from secondary sources 26
2.1.2 PRIMARY SOURCES 26
2.1.2.1 Key data from primary sources 27
2.1.2.2 Key industry insights 28
2.2 MARKET SIZE ESTIMATION 29
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 31
2.4 MARKET SHARE ESTIMATION 32
2.5 ASSUMPTIONS FOR THE STUDY 32
2.6 LIMITATIONS 32
3 EXECUTIVE SUMMARY 33
4 PREMIUM INSIGHTS 39
4.1 VETERINARY PAIN MANAGEMENT: MARKET OVERVIEW 39
4.2 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION 40
4.3 GEOGRAPHIC SNAPSHOT OF THE VETERINARY PAIN MANAGEMENT MARKET 41
4.4 VETERINARY PAIN MANAGEMENT MARKET: DEVELOPING VS. DEVELOPED COUNTRIES/REGIONS 42
4.5 VETERINARY PAIN MANAGEMENT MARKET: REGIONAL MIX 42
5 MARKET OVERVIEW 43
5.1 INTRODUCTION 43
5.2 MARKET DYNAMICS 43
5.2.1 DRIVERS 44
5.2.1.1 Growth in companion animal adoption 44
5.2.1.2 Growth in the number of veterinary practitioners and their income levels in developed economies 44
5.2.1.3 Growing prevalence of animal diseases causing pain and inflammation 45
5.2.1.4 Rising demand for pet insurance with growing animal health expenditure 46
5.2.2 RESTRAINT 47
5.2.2.1 Increasing pet care costs 47
5.2.3 OPPORTUNITIES 47
5.2.3.1 Increasing popularity of non-conventional and non-pharmaceutical treatment techniques 47
5.2.3.2 Untapped emerging markets 48
5.2.4 CHALLENGES 48
5.2.4.1 Low animal healthcare awareness in emerging markets 48
5.2.4.2 Stringent regulatory approval process for pain management drugs 48
5.3 REGULATORY ANALYSIS 49
6 VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT 53
6.1 INTRODUCTION 54
6.2 DRUGS 55
6.2.1 DRUGS, BY TYPE 55
6.2.1.1 NSAIDs 56
6.2.1.2 Opioids 57
6.2.1.3 Local Anesthetics 59
6.2.1.4 Alpha-2 Agonists 60
6.2.1.5 Disease-modifying Osteoarthritis Drugs (DMOADs) 61
6.2.1.6 Other Drugs 62
6.2.2 DRUGS, BY ROUTE OF ADMINISTRATION 63
6.2.2.1 Oral 64
6.2.2.2 Parenteral 65
6.2.2.3 Topical 66
6.3 DEVICES 68
6.3.1 LASER THERAPY DEVICES 68
6.3.2 ELECTROMAGNETIC THERAPY DEVICES 69
7 VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION 71
7.1 INTRODUCTION 72
7.2 JOINT PAIN 73
7.2.1 OSTEOARTHRITIS 73
7.2.2 MUSCULOSKELETAL DISORDERS 74
7.3 POSTOPERATIVE PAIN 76
7.4 CANCER 77
7.5 OTHER APPLICATIONS 78
 
8 VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE 80
8.1 INTRODUCTION 81
8.2 COMPANION ANIMALS 82
8.2.1 DOGS 83
8.2.2 CATS 86
8.2.3 HORSES 87
8.2.4 OTHER COMPANION ANIMALS 89
8.3 LIVESTOCK 90
8.3.1 CATTLE 92
8.3.2 SWINE 93
8.3.3 OTHER LIVESTOCK 95
9 VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL 96
9.1 INTRODUCTION 97
9.2 VETERINARY HOSPITALS & CLINICS 98
9.3 PHARMACY 100
10 VETERINARY PAIN MANAGEMENT MARKET, BY REGION 101
10.1 INTRODUCTION 102
10.2 NORTH AMERICA 103
10.2.1 US 109
10.2.2 CANADA 113
10.3 EUROPE 119
10.3.1 GERMANY 125
10.3.2 UK 130
10.3.3 FRANCE 135
10.3.4 ITALY 140
10.3.5 SPAIN 145
10.3.6 REST OF EUROPE (ROE) 149
10.4 ASIA PACIFIC 155
10.4.1 CHINA 161
10.4.2 JAPAN 166
10.4.3 INDIA 171
10.4.4 REST OF ASIA PACIFIC (REST OF APAC) 175
10.5 LATIN AMERICA 181
10.6 MIDDLE EAST AND AFRICA 186
11 COMPETITIVE LANDSCAPE 192
11.1 OVERVIEW 192
11.2 PRODUCT PORTFOLIO MIX 193
11.3 GROWTH STRATEGY MATRIX 193
11.4 MARKET SHARE ANALYSIS, 2017 194
11.5 COMPETITIVE SITUATION AND TRENDS 195
11.5.1 ACQUISITIONS 195
11.5.2 PRODUCT LAUNCHES 196
11.5.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 196
11.5.4 EXPANSIONS 197
12 COMPANY PROFILES 198
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 BOEHRINGER INGELHEIM 198
12.2 ZOETIS 201
12.3 ELANCO 204
12.4 MERCK ANIMAL HEALTH 207
12.5 BAYER 210
12.6 VETOQUINOL 213
12.7 NORBROOK LABORATORIES 215
12.8 CEVA SANTÉ ANIMALE 217
12.9 DECHRA PHARMACEUTICALS 220
12.10 CHANELLE 223
12.11 K-LASER USA 224
12.12 ASSISI ANIMAL HEALTH 225

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX 226
13.1 INSIGHTS OF INDUSTRY EXPERTS 226
13.2 DISCUSSION GUIDE 227
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 231
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 233
13.5 AVAILABLE CUSTOMIZATIONS 235
13.6 RELATED REPORTS 236
13.7 AUTHOR DETAILS 237

LIST OF TABLES

TABLE 1 VETERINARY PAIN MANAGEMENT MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 43
TABLE 2 COMPANION ANIMAL POPULATION, BY COUNTRY, 2016 (MILLION) 44
TABLE 3 DEVELOPED ECONOMIES: NUMBER OF VETERINARY PROFESSIONALS
(2012–2016) 45
TABLE 4 RECENT DEVELOPMENTS IN REGULATIONS FOR PAIN MANAGEMENT DRUGS IN THE US 51
TABLE 5 VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 54
TABLE 6 VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE,
2016–2023 (USD MILLION) 55
TABLE 7 VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 56
TABLE 8 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS MARKET,
BY COUNTRY, 2016–2023 (USD MILLION) 57
TABLE 9 OPIOIDS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 58
TABLE 10 LOCAL ANESTHETICS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 59
TABLE 11 ALPHA-2 AGONISTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 60
TABLE 12 DISEASE-MODIFYING OSTEOARTHRITIS DRUGS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 61
TABLE 13 OTHER VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 62
TABLE 14 ROUTES OF ADMINISTRATION OF MAJOR VETERINARY PAIN MANAGEMENT DRUGS 63
TABLE 15 VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD MILLION) 64
TABLE 16 ORAL VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 65
TABLE 17 PARENTERAL VETERINARY PAIN MANAGEMENT DRUGS MARKET,
BY COUNTRY, 2016–2023 (USD MILLION) 66
TABLE 18 TOPICAL VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 67
TABLE 19 VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE,
2016–2023 (USD MILLION) 68
TABLE 20 LASER THERAPY DEVICES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 69
TABLE 21 ELECTROMAGNETIC THERAPY DEVICES MARKET, BY REGION,
2016–2023 (USD MILLION) 70
TABLE 22 VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 72
TABLE 23 VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN,
BY TYPE, 2016–2023 (USD MILLION) 73
TABLE 24 VETERINARY PAIN MANAGEMENT MARKET FOR OSTEOARTHRITIS,
BY COUNTRY, 2016–2023 (USD MILLION) 74
TABLE 25 VETERINARY PAIN MANAGEMENT MARKET FOR MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2016–2023 (USD MILLION) 75
TABLE 26 VETERINARY PAIN MANAGEMENT MARKET FOR POSTOPERATIVE PAIN,
BY COUNTRY, 2016–2023 (USD MILLION) 76
TABLE 27 VETERINARY PAIN MANAGEMENT DRUG MARKET FOR CANCER,
BY COUNTRY, 2016–2023 (USD MILLION) 78
TABLE 28 VETERINARY PAIN MANAGEMENT MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2016–2023 (USD MILLION) 79
TABLE 29 VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE,
2016–2023 (USD MILLION) 81
TABLE 30 VETERINARY PAIN MANAGEMENT FOR COMPANION ANIMALS,
BY TYPE, 2016–2023 (USD MILLION) 82
TABLE 31 VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS,
BY COUNTRY, 2016–2023 (USD MILLION) 83
TABLE 32 PET DOG POPULATION, BY COUNTRY, 2010–2016 (MILLION) 84
TABLE 33 VETERINARY PAIN MANAGEMENT MARKET FOR DOGS, BY COUNTRY,
2016–2023 (USD MILLION) 85
TABLE 34 VETERINARY PAIN MANAGEMENT MARKET FOR CATS, BY COUNTRY,
2016–2023 (USD MILLION) 87
TABLE 35 PET HORSE POPULATION, BY COUNTRY, 2012–2016 (THOUSANDS) 88
TABLE 36 VETERINARY PAIN MANAGEMENT MARKET FOR HORSES, BY COUNTRY,
2016–2023 (USD MILLION) 89
TABLE 37 VETERINARY PAIN MANAGEMENT MARKET FOR OTHER COMPANION ANIMALS,
BY COUNTRY, 2016–2023 (USD MILLION) 90
TABLE 38 VETERINARY PAIN MANAGEMENT FOR LIVESTOCK, BY TYPE,
2016–2023 (USD MILLION) 91
TABLE 39 VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK,
BY COUNTRY, 2016–2023 (USD MILLION) 91
TABLE 40 CATTLE POPULATION, BY COUNTRY, 2012–2016 (THOUSANDS) 92
TABLE 41 VETERINARY PAIN MANAGEMENT MARKET FOR CATTLE, BY COUNTRY,
2016–2023 (USD MILLION) 93
TABLE 42 VETERINARY PAIN MANAGEMENT MARKET FOR SWINE, BY COUNTRY,
2016–2023 (USD MILLION) 94
TABLE 43 VETERINARY PAIN MANAGEMENT MARKET FOR OTHER LIVESTOCK,
BY COUNTRY, 2016–2023 (USD MILLION) 95
TABLE 44 VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL,
2016–2023 (USD MILLION) 97
TABLE 45 NUMBER OF PRIVATE CLINICAL PRACTICES, BY COUNTRY, 2012 VS. 2016 98
TABLE 46 VETERINARY PAIN MANAGEMENT MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2016–2023 (USD MILLION) 99
TABLE 47 VETERINARY PAIN MANAGEMENT MARKET FOR PHARMACY,
BY COUNTRY, 2016–2023 (USD MILLION) 100
TABLE 48 VETERINARY PAIN MANAGEMENT MARKET, BY REGION,
2016–2023 (USD MILLION) 103
TABLE 49 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET,
BY COUNTRY, 2016–2023 (USD MILLION) 105
TABLE 50 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET,
BY PRODUCT, 2016–2023 (USD MILLION) 105
TABLE 51 NORTH AMERICA: VETERINARY PAIN MANAGEMENT DRUGS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 105
TABLE 52 NORTH AMERICA: VETERINARY PAIN MANAGEMENT DRUGS MARKET,
BY ROUTE OF ADMINISTRATION, 2016–2023 (USD MILLION) 106
TABLE 53 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 106
TABLE 54 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN,
BY TYPE, 2016–2023 (USD MILLION) 107
TABLE 55 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2016–2023 (USD MILLION) 107
TABLE 56 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016–2023 (USD MILLION) 107
TABLE 57 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK,
BY TYPE, 2016–2023 (USD MILLION) 108
TABLE 58 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016–2023 (USD MILLION) 108
TABLE 59 US: NUMBER OF HOUSEHOLDS THAT OWNED PETS, BY TYPE OF COMPANION ANIMAL, 2010 VS. 2016 (MILLION) 109
TABLE 60 US: PRIVATE CLINICAL PRACTICE, BY ANIMAL TYPE, 2012 VS. 2017 109
TABLE 61 US: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 110
TABLE 62 US: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE,
2016–2023 (USD MILLION) 110
TABLE 63 US: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD MILLION) 111
TABLE 64 US: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 111
TABLE 65 US: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN,
BY TYPE, 2016–2023 (USD MILLION) 111
TABLE 66 US: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE,
2016–2023 (USD MILLION) 112
TABLE 67 US: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS,
BY TYPE, 2016–2023 (USD MILLION) 112
TABLE 68 US: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK, BY TYPE,
2016–2023 (USD MILLION) 113
TABLE 69 US: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016–2023 (USD MILLION) 113
TABLE 70 COMPANION ANIMAL POPULATION IN CANADA, 2011 VS. 2016 (MILLION) 114
TABLE 71 CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 114
TABLE 72 CANADA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE,
2016–2023 (USD MILLION) 115
TABLE 73 CANADA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD MILLION) 115
TABLE 74 CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 116
TABLE 75 CANADA: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN,
BY TYPE, 2016–2023 (USD MILLION) 116
TABLE 76 CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE,
2016–2023 (USD MILLION) 117
TABLE 77 CANADA: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016–2023 (USD MILLION) 117
TABLE 78 CANADA: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK,
BY TYPE, 2016–2023 (USD MILLION) 118
TABLE 79 CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016–2023 (USD MILLION) 118
TABLE 80 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 121
TABLE 81 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 121
TABLE 82 EUROPE: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE,
2016–2023 (USD MILLION) 122
TABLE 83 EUROPE: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD MILLION) 122
TABLE 84 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 123
TABLE 85 EUROPE: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN,
BY TYPE, 2016–2023 (USD MILLION) 123
TABLE 86 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE,
2016–2023 (USD MILLION) 123
TABLE 87 EUROPE: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016–2023 (USD MILLION) 124
TABLE 88 EUROPE: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK,
BY TYPE, 2016–2023 (USD MILLION) 124
TABLE 89 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016–2023 (USD MILLION) 125
TABLE 90 GERMANY: COMPANION ANIMAL POPULATION, (2010–2016) (MILLION) 126
TABLE 91 GERMANY: NUMBER OF VETERINARIANS, BY TYPE OF PRACTICE, 2014 VS. 2016 126
TABLE 92 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 126
TABLE 93 GERMANY: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE,
2016–2023 (USD MILLION) 127
TABLE 94 GERMANY: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD MILLION) 127
TABLE 95 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 128
TABLE 96 GERMANY: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN,
BY TYPE, 2016–2023 (USD MILLION) 128
TABLE 97 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE,
2016–2023 (USD MILLION) 128
TABLE 98 GERMANY: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016–2023 (USD MILLION) 129
TABLE 99 GERMANY: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK,
BY TYPE, 2016–2023 (USD MILLION) 129
TABLE 100 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016–2023 (USD MILLION) 130
TABLE 101 UK: COMPANION ANIMAL POPULATION, (2010–2016) (MILLION) 131
TABLE 102 UK: NUMBER OF VETERINARIANS, BY TYPE OF PRACTICE, 2014 VS. 2016 131
TABLE 103 UK: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 131
TABLE 104 UK: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE,
2016–2023 (USD MILLION) 132
TABLE 105 UK: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD MILLION) 132
TABLE 106 UK: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 133
TABLE 107 UK: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN,
BY TYPE, 2016–2023 (USD MILLION) 133
TABLE 108 UK: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE,
2016–2023 (USD MILLION) 133
TABLE 109 UK: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS,
BY TYPE, 2016–2023 (USD MILLION) 134
TABLE 110 UK: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK, BY TYPE,
2016–2023 (USD MILLION) 134
TABLE 111 UK: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016–2023 (USD MILLION) 135
TABLE 112 FRANCE: COMPANION ANIMAL POPULATION, (2010–2016) (MILLION) 136
TABLE 113 FRANCE: NUMBER OF VETERINARIANS, BY TYPE OF PRACTICE, 2014 VS. 2016 136
TABLE 114 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 136
TABLE 115 FRANCE: VETERINARY PAIN MANAGEMENT DRUGS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 137
TABLE 116 FRANCE: VETERINARY PAIN MANAGEMENT DRUGS MARKET,
BY ROUTE OF ADMINISTRATION, 2016–2023 (USD MILLION) 137
TABLE 117 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 138
TABLE 118 FRANCE: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN,
BY TYPE, 2016–2023 (USD MILLION) 138
TABLE 119 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE,
2016–2023 (USD MILLION) 138
TABLE 120 FRANCE: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016–2023 (USD MILLION) 139
TABLE 121 FRANCE: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK,
BY TYPE, 2016–2023 (USD MILLION) 139
TABLE 122 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016–2023 (USD MILLION) 140
TABLE 123 ITALY: FOOD-PRODUCING ANIMAL POPULATION, 2010-2016 (MILLION) 141
TABLE 124 ITALY: NUMBER OF VETERINARIANS, 2012 VS. 2016 141
TABLE 125 ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 141
TABLE 126 ITALY: VETERINARY PAIN MANAGEMENT DRUGS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 142
TABLE 127 ITALY: VETERINARY PAIN MANAGEMENT DRUGS MARKET,
BY ROUTE OF ADMINISTRATION, 2016–2023 (USD MILLION) 142
TABLE 128 ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 143
TABLE 129 ITALY: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN,
BY TYPE, 2016–2023 (USD MILLION) 143
TABLE 130 ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE,
2016–2023 (USD MILLION) 143
TABLE 131 ITALY: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS,
BY TYPE, 2016–2023 (USD MILLION) 144
TABLE 132 ITALY: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK,
BY TYPE, 2016–2023 (USD MILLION) 144
TABLE 133 ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016–2023 (USD MILLION) 145
TABLE 134 SPAIN: FOOD-PRODUCING ANIMAL POPULATION, 2010-2016 (MILLION) 145
TABLE 135 SPAIN: NUMBER OF VETERINARIANS, 2014 146
TABLE 136 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 146
TABLE 137 SPAIN: VETERINARY PAIN MANAGEMENT DRUGS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 146
TABLE 138 SPAIN: VETERINARY PAIN MANAGEMENT DRUGS MARKET,
BY ROUTE OF ADMINISTRATION, 2016–2023 (USD MILLION) 147
TABLE 139 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 147
TABLE 140 SPAIN: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN,
BY TYPE, 2016–2023 (USD MILLION) 147
TABLE 141 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE,
2016–2023 (USD MILLION) 148
TABLE 142 SPAIN: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS,
BY TYPE, 2016–2023 (USD MILLION) 148
TABLE 143 SPAIN: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK,
BY TYPE, 2016–2023 (USD MILLION) 149
TABLE 144 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016–2023 (USD MILLION) 149
TABLE 145 ROE: COMPANION ANIMAL POPULATION, 2016 (MILLION) 150
TABLE 146 ROE: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 150
TABLE 147 ROE: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE,
2016–2023 (USD MILLION) 151
TABLE 148 ROE: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD MILLION) 151
TABLE 149 ROE: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 152
TABLE 150 ROE: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN,
BY TYPE, 2016–2023 (USD MILLION) 152
TABLE 151 ROE: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE,
2016–2023 (USD MILLION) 153
TABLE 152 ROE: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS,
BY TYPE, 2016–2023 (USD MILLION) 153
TABLE 153 ROE: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK,
BY TYPE, 2016–2023 (USD MILLION) 154
TABLE 154 ROE: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016–2023 (USD MILLION) 154
TABLE 155 ASIA PACIFIC: FOOD-PRODUCING ANIMAL POPULATION, (2010-2016) (MILLION) 155
TABLE 156 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 157
TABLE 157 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 157
TABLE 158 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT DRUGS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 158
TABLE 159 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT DRUGS MARKET,
BY ROUTE OF ADMINISTRATION, 2016–2023 (USD MILLION) 158
TABLE 160 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 159
TABLE 161 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN,
BY TYPE, 2016–2023 (USD MILLION) 159
TABLE 162 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE,
2016–2023 (USD MILLION) 159
TABLE 163 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016–2023 (USD MILLION) 160
TABLE 164 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK,
BY TYPE, 2016–2023 (USD MILLION) 160
TABLE 165 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016–2023 (USD MILLION) 161
TABLE 166 CHINA: FOOD-PRODUCING ANIMAL POPULATION, (2010-2016) (MILLION) 162
TABLE 167 CHINA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 162
TABLE 168 CHINA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE,
2016–2023 (USD MILLION) 162
TABLE 169 CHINA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD MILLION) 163
TABLE 170 CHINA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 163
TABLE 171 CHINA: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN,
BY TYPE, 2016–2023 (USD MILLION) 164
TABLE 172 CHINA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE,
2016–2023 (USD MILLION) 164
TABLE 173 CHINA: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS,
BY TYPE, 2016–2023 (USD MILLION) 164
TABLE 174 CHINA: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK,
BY TYPE, 2016–2023 (USD MILLION) 165
TABLE 175 CHINA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016–2023 (USD MILLION) 165
TABLE 176 JAPAN: FOOD-PRODUCING ANIMAL POPULATION, (2010-2016) (MILLION) 166
TABLE 177 JAPAN: NUMBER OF VETERINARIANS, 2010 VS. 2016 166
TABLE 178 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 167
TABLE 179 JAPAN: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE,
2016–2023 (USD MILLION) 167
TABLE 180 JAPAN: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD MILLION) 168
TABLE 181 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 168
TABLE 182 JAPAN: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN,
BY TYPE, 2016–2023 (USD MILLION) 168
TABLE 183 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE,
2016–2023 (USD MILLION) 169
TABLE 184 JAPAN: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS,
BY TYPE, 2016–2023 (USD MILLION) 169
TABLE 185 JAPAN: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK,
BY TYPE, 2016–2023 (USD MILLION) 170
TABLE 186 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016–2023 (USD MILLION) 170
TABLE 187 INDIA: FOOD-PRODUCING ANIMAL POPULATION (2010-2016) (MILLION) 171
TABLE 188 INDIA: NUMBER OF VETERINARIANS, 2014 172
TABLE 189 INDIA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 172
TABLE 190 INDIA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE,
2016–2023 (USD MILLION) 172
TABLE 191 INDIA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD MILLION) 173
TABLE 192 INDIA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 173
TABLE 193 INDIA: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN,
BY TYPE, 2016–2023 (USD MILLION) 173
TABLE 194 INDIA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE,
2016–2023 (USD MILLION) 174
TABLE 195 INDIA: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS,
BY TYPE, 2016–2023 (USD MILLION) 174
TABLE 196 INDIA: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK,
BY TYPE, 2016–2023 (USD MILLION) 175
TABLE 197 INDIA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016–2023 (USD MILLION) 175
TABLE 198 ROAPAC: FOOD PRODUCING ANIMAL POPULATION (2010-2016) (MILLION) 176
TABLE 199 ROAPAC: NUMBER OF VETERINARIANS 177
TABLE 200 ROAPAC: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 177
TABLE 201 ROAPAC: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE,
2016–2023 (USD MILLION) 177
TABLE 202 ROAPAC: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2023 (USD MILLION) 178
TABLE 203 ROAPAC: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 178
TABLE 204 ROAPAC: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN,
BY TYPE, 2016–2023 (USD MILLION) 178
TABLE 205 ROAPAC: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE,
2016–2023 (USD MILLION) 179
TABLE 206 ROAPAC: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016–2023 (USD MILLION) 179
TABLE 207 ROAPAC: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK,
BY TYPE, 2016–2023 (USD MILLION) 180
TABLE 208 ROAPAC: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016–2023 (USD MILLION) 180
TABLE 209 NUMBER OF VETERINARIANS AND VETERINARY PARA-PROFESSIONALS IN LATIN AMERICAN COUNTRIES, 2010 VS 2016 181
TABLE 210 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 182
TABLE 211 LATIN AMERICA: VETERINARY PAIN MANAGEMENT DRUGS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 182
TABLE 212 LATIN AMERICA: VETERINARY PAIN MANAGEMENT DRUGS MARKET,
BY ROUTE OF ADMINISTRATION, 2016–2023 (USD MILLION) 183
TABLE 213 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 183
TABLE 214 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN,
BY TYPE, 2016–2023 (USD MILLION) 184
TABLE 215 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2016–2023 (USD MILLION) 184
TABLE 216 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016–2023 (USD MILLION) 184
TABLE 217 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK,
BY TYPE, 2016–2023 (USD MILLION) 185
TABLE 218 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2016–2023 (USD MILLION) 185
TABLE 219 NUMBER OF VETERINARIANS AND VETERINARY PARA-PROFESSIONALS IN THE MIDDLE EAST & AFRICA, 2010 VS 2016 187
TABLE 220 MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT MARKET,
BY PRODUCT, 2016–2023 (USD MILLION) 187
TABLE 221 MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT DRUGS MARKET,
BY TYPE, 2016–2023 (USD MILLION) 188
TABLE 222 MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT DRUGS MARKET,
BY ROUTE OF ADMINISTRATION, 2016–2023 (USD MILLION) 188
TABLE 223 MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT MARKET,
BY APPLICATION, 2016–2023 (USD MILLION) 189
TABLE 224 MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2016–2023 (USD MILLION) 189
TABLE 225 MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT MARKET,
BY ANIMAL TYPE, 2016–2023 (USD MILLION) 190
TABLE 226 MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2016–2023 (USD MILLION) 190
TABLE 227 MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK, BY TYPE, 2016–2023 (USD MILLION) 191
TABLE 228 MIDDLE EAST & AFRICA: VETERINARY PAIN MANAGEMENT MARKET,
BY DISTRIBUTION CHANNEL, 2016–2023 (USD MILLION) 191
TABLE 229 KEY ACQUISITIONS, JANUARY 2014 – FEBRUARY 2018 195
TABLE 230 KEY PRODUCT LAUNCHES, JANUARY 2014– FEBRUARY 2018 196
TABLE 231 KEY AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS,
JANUARY 2014 – FEBRUARY 2018 196
TABLE 232 KEY EXPANSIONS, JANUARY 2014 – FEBRUARY 2018 197


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 24
FIGURE 2 PRIMARY SOURCES 26
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS(SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 28
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS(DEMAND SIDE):
BY DISTRIBUTION CHANNEL, AND REGION 29
FIGURE 5 BOTTOM-UP APPROACH 30
FIGURE 6 TOP-DOWN APPROACH 30
FIGURE 7 DATA TRIANGULATION METHODOLOGY 31
FIGURE 8 VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT,
2018 VS. 2023 (USD MILLION) 33
FIGURE 9 VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE,
2018 VS. 2023 (USD MILLION) 34
FIGURE 10 VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2018 VS. 2023 (USD MILLION) 34
FIGURE 11 VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE,
2018 VS. 2023 (USD MILLION) 35
FIGURE 12 VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION,
2018 VS. 2023 (USD MILLION) 36
FIGURE 13 VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE,
2018 VS. 2023 (USD MILLION) 36
FIGURE 14 VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL,
2018 VS. 2023 (USD MILLION) 37
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF THE VETERINARY PAIN MANAGEMENT MARKET 38
FIGURE 16 GROWTH IN COMPANION ANIMAL ADOPTION AND INCREASING PREVALENCE OF ANIMAL DISEASES IS DRIVING MARKET GROWTH 39
FIGURE 17 CHINA ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2017 40
FIGURE 18 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2017 41
FIGURE 19 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 42
FIGURE 20 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 42
FIGURE 21 NORTH AMERICAN PET HEALTH INSURANCE MARKET, 2012–2016 (USD MILLION) 46
FIGURE 22 DEVELOPMENT AND APPROVAL PROCESS FOR ANIMAL PHARMACEUTICAL PRODUCTS 50
FIGURE 23 APPROVAL PROCESS FOR ANIMAL PHARMACEUTICAL PRODUCTS IN EUROPE 52
FIGURE 24 DRUGS SEGMENT TO DOMINATE THE VETERINARY PAIN MANAGEMENT MARKET DURING THE FORECAST PERIOD 54
FIGURE 25 NSAIDS TO DOMINATE THE VETERINARY PAIN MANAGEMENT DRUGS MARKET DURING THE FORECAST PERIOD 55
FIGURE 26 JOINT PAIN TO DOMINATE THE VETERINARY PAIN MANAGEMENT MARKET DURING THE FORECAST PERIOD 72
FIGURE 27 COMPANION ANIMALS SEGMENT TO DOMINATE THE VETERINARY PAIN MANAGEMENT MARKET DURING THE FORECAST PERIOD 81
FIGURE 28 EUROPE: PET CAT POPULATION, BY COUNTRY, 2016 (THOUSANDS) 86
FIGURE 29 PER CAPITA PORK CONSUMPTION FROM 2006–2017 (POUNDS) 94
FIGURE 30 HOSPITALS & CLINICS FORMED THE LARGEST DISTRIBUTION CHANNEL FOR VETERINARY PAIN MANAGEMENT DRUGS AND DEVICES 97
FIGURE 31 VETERINARY PAIN MANAGEMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 102
FIGURE 32 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET SNAPSHOT 104
FIGURE 33 EUROPE: VETERINARY PAIN MANAGEMENT MARKET SNAPSHOT 120
FIGURE 34 APAC: VETERINARY PAIN MANAGEMENT MARKET SNAPSHOT 156
FIGURE 35 KEY DEVELOPMENTS IN THE VETERINARY PAIN MANAGEMENT MARKET BETWEEN JANUARY 2014 AND FEBRUARY 2018 192
FIGURE 36 VETERINARY PAIN MANAGEMENT DRUGS MARKET SHARE ANALYSIS,
BY KEY PLAYER, 2017 194
FIGURE 37 BOEHRINGER INGELHEIM: COMPANY SNAPSHOT (2016) 198
FIGURE 38 ZOETIS: COMPANY SNAPSHOT (2016) 201
FIGURE 39 ELI LILLY AND COMPANY: COMPANY SNAPSHOT (2016) 204
FIGURE 40 MERCK ANIMAL HEALTH: COMPANY SNAPSHOT (2016) 207
FIGURE 41 BAYER: COMPANY SNAPSHOT (2016) 210
FIGURE 42 VETOQUINOL: COMPANY SNAPSHOT (2016) 213
FIGURE 43 NORBROOK LABORATORIES: COMPANY SNAPSHOT (2016) 215
FIGURE 44 CEVA SANTÉ ANIMALE: COMPANY SNAPSHOT (2016) 217
FIGURE 45 DECHRA PHARMACEUTICALS: COMPANY SNAPSHOT (2017) 220


【レポートのキーワード】

動物、動物医薬品、痛み管理、疼痛治療

★調査レポート[動物向け疼痛治療の世界市場予測（～2023年）] ( Veterinary Pain Management Market by Product (Drugs (NSAIDs, Opioids), Device (Laser, Electromagnetic)), Application (Osteoarthritis, Cancer), Animal Type (Dog, Cat, Horse, Cattle), Distribution Channel (Hospital, Pharmacy) - Global Forecast to 2023 / MD6197) 販売に関する免責事項
[動物向け疼痛治療の世界市場予測（～2023年）] ( Veterinary Pain Management Market by Product (Drugs (NSAIDs, Opioids), Device (Laser, Electromagnetic)), Application (Osteoarthritis, Cancer), Animal Type (Dog, Cat, Horse, Cattle), Distribution Channel (Hospital, Pharmacy) - Global Forecast to 2023 / MD6197) についてEメールでお問い合わせ
◆関連調査資料◆
  • 動物用内視鏡の世界市場予測（～2023年）
    MD6426 / MarketsandMarkets / 2018年7月5日 / MarketsandMarketsが発行した当調査レポートでは、動物用内視鏡の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品タイプ別（フレキシブル内視鏡、ビデオスコープ、ファイバースコープ、リジッドスコープ）分析、処置別（気管支鏡検査、腹腔鏡検査、胃十二指腸内視鏡検査、大腸内視鏡検査、鼻鏡検査）分析、動物タイプ別（コンパニオンアニマル、大型）分析、エンドユーザー別（病院、診療所）分析、動物用内視鏡の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The global veterinary endoscopy market is projected to grow at a CAGR of 6.5% during the forecast period.”The veterinary endoscopy market is expected to reach USD 219.0 million by 2023 from USD 159.8 million in 2018, at a CAGR of 6.5%. The increasing use of endoscopes in the diagnosis of gastrointestinal diseases, rising number of veterinary endoscopy training programs, advanced applications of veterinary endoscopy, increasing pet insurance and growing animal health expenditure, growing population of companion animals, rising demand for animal-derived food products, and growth in the number of veterinary practitioners are the major factors driving the growth of this...
  • 獣医用機器および消耗品の世界市場予測（～2023年）：消耗品、麻酔機、人工呼吸器、患者モニター、酸素マスク、輸液ポンプ
    MD-3898 / MarketsandMarkets / 2018年8月27日 / MarketsandMarketsが発行した当調査レポートでは、獣医用機器および消耗品の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、製品別（消耗品、麻酔機、人工呼吸器、患者モニター、酸素マスク、輸液ポンプ）分析、動物の種別（ネコ、イヌ、ウマ、ウシ）分析、エンドユーザー別（病院、診療所）分析、獣医用機器および消耗品の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global veterinary equipment and disposables market is projected to 2.40 billion by 2023 from USD 1.63 billion in 2018, at a CAGR of 8.0% during the forecast period of 2018 to 2023. Rising animal health expenditure and a growing demand for pet insurance, increasing number of veterinary practitioners in developed regions, and growth in the companion animals market are the primary drivers for the global veterinary equipment and disposables market during the forecast period. The report analyzes the global veterinary equipment and disposables market by type, animal, end user, and region. On the basis of type, the critical care...
  • 動物診断の世界市場予測（～2023年）：動物診断機器、動物診断消耗品
    MD2411 / MarketsandMarkets / 2018年7月24日 / MarketsandMarketsが発行した当調査レポートでは、動物診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品別（機器、消耗品）分析、技術別（臨床生化学、尿検査、免疫診断、血液学、分子診断）分析、動物の種類別（犬、猫、馬、牛、豚、家禽）分析、エンドユーザー別分析、動物診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The veterinary diagnostics market is projected to reach USD 4.00 billion by 2023 from USD 2.63 billion in 2018, at a CAGR of 8.8%. Factors such as growing companion animal population, growing prevalence of animal zoonotic diseases, rising demand for animal-derived food products, rising demand for pet insurance & growing animal health expenditure, and the increasing number of veterinary practitioners and income levels in developed economies are expected to drive the growth of the veterinary diagnostics market. However, the increasing pet care costs may restrain the growth of the market. The market is segmented based on the product, technology, animal...
  • 疼痛の寒冷療法の世界市場予測（～2023年）
    MD-4660 / MarketsandMarkets / 2018年6月7日 / MarketsandMarketsが発行した当調査レポートでは、疼痛の寒冷療法の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（OTC、処方ベース）別分析、用途別分析、地域別分析、疼痛の寒冷療法の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The cold pain therapy market is projected to grow at a CAGR of 4.6%.”The global cold pain therapy market is projected to reach USD 2.12 billion by 2023 from USD 1.69 billion in 2018, at a CAGR of 4.6%. The increasing incidence of sports injuries and rising emphasis on exercise and gym activities, growing number of hip and knee surgeries across the globe, and growing need for safer pain management modalities as opposed to oral drug therapy are expected to drive the demand for cold pain therapy products during the study period. On the other hand, lack of reimbursement and...
  • 治療薬モニタリングの世界市場予測（～2023年）
    MD-4185 / MarketsandMarkets / 2018年8月22日 / MarketsandMarketsが発行した当調査レポートでは、治療薬モニタリングの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別（消耗品、装置）分析、技術別（蛍光免疫測定、放射免疫測定法、GCMS）分析、薬剤クラス別（抗生物質、気管支拡張剤）分析、エンドユーザー別（病院内ラボ）分析、治療薬モニタリングの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global therapeutic drug monitoring (TDM) market is projected to reach USD 1.63 billion by 2023 from USD 1.23 billion in 2018, at a CAGR of 5.9% during the forecast period. Market growth is largely driven by factors rising number of organ transplant procedures and the use of TDM in traditional anticancer therapies. In this report, the market has been categorized based on product, class of drugs, technology, end user, and region. On the basis of technology, the therapeutic drug monitoring market is segmented into immunoassay and chromatography & MS. In 2018, the immunoassay segment is expected to account for...
  • ハイスループットスクリーニング（HTS）の世界市場予測（～2023年）：細胞アッセイ、Lab-on-a-chip、バイオインフォマティクス
    BT2220 / MarketsandMarkets / 2018年4月24日 / 当調査レポートでは、ハイスループットスクリーニング（HTS）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、技術（細胞アッセイ、Lab-on-a-chip、バイオインフォマティクス）別分析、用途別分析、製品別分析、需要先別分析、ハイスループットスクリーニング（HTS）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global high-throughput screening (HTS) market is projected to reach USD 21.69 Billion by 2023 from USD 14.87 Billion in 2018, at a CAGR of 7.8%. The major factors driving the growth of the HTS market include initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological advancements in HTS, and the availability of government funding and venture capital investments. The report analyzes the global HTS market by product & service, technology, application, end user, and region. On the basis of product & service, the reagents & assay kits segment accounted for the largest share of the global HTS...
  • 薬剤注入ポンプの世界市場予測（～2023年）：製品、用途、エンドユーザー、地域別分析
    MAM-MD-2368 / MarketsandMarkets / 2018年4月4日 / MarketsandMarketsが発行した当調査レポートでは、薬剤注入ポンプの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、市場環境分析、製品別分析、用途別分析、エンドユーザー別分析、地域別分析、薬剤注入ポンプの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The infusion pumps market is projected to grow at a CAGR of 6.0% between 2018 and 2023”The infusion pumps market is expected to reach USD 15.89 billion by 2023 from USD 11.90 billion in 2018, at a CAGR of 6.0%. The overall growth of the infusion pumps market is largely driven by the increasing incidence of chronic diseases along with the rapid growth in the geriatric population, rising demand for ambulatory infusion pumps, and the growing volume of surgical procedures performed. In addition, untapped, emerging markets such as India and China and the growing adoption of specialty infusion pumps are...
  • 気道確保装置の世界市場予測（～2023年）
    MD6439 / MarketsandMarkets / 2018年7月9日 / MarketsandMarketsが発行した当調査レポートでは、気道確保装置の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、タイプ別（声門上器具、声門下器具、人工蘇生器、喉頭鏡）分析、エンドユーザー別（OR、ICU）分析、患者年齢別（成人、小児）分析、気道確保装置の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。... “The airway management devices market is projected to grow at a CAGR of 5.6%.”The global airway management devices market is projected to reach USD 2.10 billion by 2023 from an estimated USD 1.60 billion in 2018, at a CAGR of 5.6% during the forecast period. Rising prevalence of chronic respiratory diseases, increasing demand for emergency care, and high incidence of preterm babies are driving the demand for airway management devices. However, harmful effects of certain devices on neonates and dearth of skilled professionals are posing a challenge for the growth of the market. “In 2018, the infraglottic devices segment...
  • 歯科矯正用品の世界市場予測（～2023年）
    MAM-MD-3645 / MarketsandMarkets / 2018年4月12日 / MarketsandMarketsが発行した当調査レポートでは、歯科矯正用品の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、患者別分析、地域別分析、歯科矯正用品の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The global orthodontic supplies market is projected to grow at a CAGR of 8.9% in the next five years”The global orthodontic supplies market is projected to reach USD 6.63 billion by 2023 from USD 4.32 billion in 2018, growing at a CAGR of 8.9% from 2018 to 2023. Key factors driving the growth of this market include the growing number of patients with malocclusions, jaw diseases, tooth decay/tooth loss, and jaw pain; expanding middle-class population in developing countries coupled with increasing disposable incomes; and ongoing research and technological advancements in orthodontic products. However, factors such as unfavorable reimbursement policies and...
  • 空カプセルの世界市場予測（～2023年）：ゼラチン、非ゼラチン
    PH-2935 / MarketsandMarkets / 2018年10月23日 / MarketsandMarketsが発行した当調査レポートでは、空カプセルの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、タイプ別（ゼラチン、非ゼラチン）分析、機能別（徐放性、遅延放出性）分析、用途別（抗生物質、ビタミン、制酸剤）分析、エンドユーザー別（医薬品、栄養補助食品、化粧品）分析、空カプセルの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The Global Empty Capsules Market is Projected to Grow at a CAGR of 7.4% from 2018 to 2023.”The empty capsules market is projected to reach USD 2.79 billion by 2023 from an estimated USD 1.95 billion in 2018, at a CAGR of 7.4%. The growing adoption of capsule formulations among the growing geriatric population, the growth of the pharmaceutical market along with the increasing R&D activities & clinical trials, and advancements in capsule delivery technologies are the major factors driving the market for empty capsules. Emerging markets (due to their low manufacturing costs) are expected to present significant opportunities for...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆